Santa Cruz Biotechnology delivers a wide array of TFIIA-α monoclonal antibodies for research in gene expression and transcription regulation. TFIIA-α monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TFIIA-α is a crucial component of the transcription factor complex that plays a significant role in the initiation of transcription by RNA polymerase II. The protein is involved in the assembly of the pre-initiation complex and is essential for the regulation of gene expression in response to various cellular signals. Understanding TFIIA-α function is vital for elucidating the mechanisms of gene regulation and its implications in various diseases. TFIIA-α research has revealed important insights into transcriptional control mechanisms and cellular development. Investigating TFIIA-α activity helps researchers better understand its role in normal cellular processes and disease states. TFIIA-α monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance their understanding of transcriptional regulation and contribute to scientific progress in gene expression research.